Dominic ffytcheAllergan completes acquisition of AqueSysMatricellular proteins may be key therapeutic targets for common ocular disordersPrior to his moving in March 2014, David L. Epstein, MD, was the Joseph A.C. Wadsworth Clinical Professor of Ophthalmology. He was chairman of the Department of Ophthalmology at Duke University College of Medicine for 22 years. During his long career, Dr. Epstein was an active person in ARVO, where he served on the ARVO Board of Trustees and as president . In 2013, he received the association's Mildred Weisenfeld Award for Excellence in Ophthalmology for his distinguished scholarly contributions to the clinical practice of ophthalmology. He was the author of more than 230 scholarly papers and consulted in glaucoma clinical care while maintaining a dynamic glaucoma research system.He studied zoology at the University of Iowa under Emil Witschi, a famous zoologist and professional in genetics, developmental biology, and development, and began medical school at Iowa in 1955. After graduating in 1959, he began his residency and then fellowship in pediatrics at the University of Wisconsin, where he studied under Klaus Patau, Ph.D., a pioneer in medical genetics, and David W. Smith, M.D., regarded as the paternalfather of dysmorphology – the study of structural defects, particularly congenital malformations, in people. Smith released Opitz to a service in Wisconsin where severely mentally disabled kids and adults lived, and soon after that he started his life’s work of understanding how to recognize physical and biological signs and symptoms of disorders to diagnose and understand them.